Logo image of CANG

CANGO INC/KY - ADR (CANG) Stock Fundamental Analysis

NYSE:CANG - New York Stock Exchange, Inc. - US1375861036 - ADR - Currency: USD

4.84  +0.28 (+6.14%)

Fundamental Rating

3

Overall CANG gets a fundamental rating of 3 out of 10. We evaluated CANG against 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of CANG have multiple concerns. CANG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CANG had negative earnings in the past year.
The reported net income has been mixed in the past 5 years: CANG reported negative net income in multiple years.
CANG had negative operating cash flow in 4 of the past 5 years.
CANG Yearly Net Income VS EBIT VS OCF VS FCFCANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

CANG has a Return On Assets (0.04%) which is comparable to the rest of the industry.
CANG has a Return On Equity (0.08%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.04%
ROE 0.08%
ROIC N/A
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
CANG Yearly ROA, ROE, ROICCANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CANG has a Profit Margin (0.17%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CANG has grown nicely.
In the last couple of years the Operating Margin of CANG has declined.
The Gross Margin of CANG (13.27%) is worse than 90.00% of its industry peers.
In the last couple of years the Gross Margin of CANG has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 0.17%
GM 13.27%
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
CANG Yearly Profit, Operating, Gross MarginsCANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

3

2. Health

2.1 Basic Checks

CANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CANG has about the same amount of shares outstanding.
Compared to 5 years ago, CANG has less shares outstanding
The debt/assets ratio for CANG is higher compared to a year ago.
CANG Yearly Shares OutstandingCANG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CANG Yearly Total Debt VS Total AssetsCANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that CANG is in the distress zone and has some risk of bankruptcy.
CANG has a worse Altman-Z score (1.03) than 73.33% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that CANG is not too dependend on debt financing.
CANG has a Debt to Equity ratio of 0.20. This is comparable to the rest of the industry: CANG outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACCN/A
WACC8.2%
CANG Yearly LT Debt VS Equity VS FCFCANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.41 indicates that CANG should not have too much problems paying its short term obligations.
CANG has a Current ratio (1.41) which is in line with its industry peers.
CANG has a Quick Ratio of 1.41. This is a normal value and indicates that CANG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CANG (1.41) is better than 82.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
CANG Yearly Current Assets VS Current LiabilitesCANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

CANG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.42%, which is quite impressive.
The Revenue has grown by 46.68% in the past year. This is a very strong growth!
CANG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.00% yearly.
EPS 1Y (TTM)62.42%
EPS 3YN/A
EPS 5Y0%
EPS Q2Q%-330.19%
Revenue 1Y (TTM)46.68%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%1531.77%

3.2 Future

CANG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 153.90% yearly.
Based on estimates for the next years, CANG will show a very negative growth in Revenue. The Revenue will decrease by -11.26% on average per year.
EPS Next Y224.75%
EPS Next 2Y153.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-33.66%
Revenue Next 2Y-11.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CANG Yearly Revenue VS EstimatesCANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
CANG Yearly EPS VS EstimatesCANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10 15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CANG. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 1.76 indicates a rather cheap valuation of CANG.
CANG's Price/Forward Earnings ratio is rather cheap when compared to the industry. CANG is cheaper than 99.17% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.77, CANG is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.76
CANG Price Earnings VS Forward Price EarningsCANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

CANG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CANG is more expensive than 71.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 120.62
CANG Per share dataCANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

CANG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CANG's earnings are expected to grow with 153.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y153.9%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CANG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANGO INC/KY - ADR

NYSE:CANG (5/27/2025, 4:15:00 PM)

4.84

+0.28 (+6.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-27 2025-08-27
Inst Owners18.71%
Inst Owner Change-10.48%
Ins Owners1.88%
Ins Owner ChangeN/A
Market Cap502.33M
Analysts43.33
Price TargetN/A
Short Float %6.69%
Short Ratio4.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.76
P/S 2.01
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 0.95
EV/EBITDA 120.62
EPS(TTM)-0.03
EYN/A
EPS(NY)2.74
Fwd EY56.71%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.41
BVpS5.18
TBVpS5.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.04%
ROE 0.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.17%
GM 13.27%
FCFM N/A
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
F-ScoreN/A
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA 28.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 1.03
F-ScoreN/A
WACC8.2%
ROIC/WACCN/A
Cap/Depr(3y)348.58%
Cap/Depr(5y)264.99%
Cap/Sales(3y)38.63%
Cap/Sales(5y)23.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.42%
EPS 3YN/A
EPS 5Y0%
EPS Q2Q%-330.19%
EPS Next Y224.75%
EPS Next 2Y153.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.68%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%1531.77%
Revenue Next Year-33.66%
Revenue Next 2Y-11.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-162.18%
EBIT growth 3Y-4.73%
EBIT growth 5Y-15.84%
EBIT Next Year29.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-220.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-130.21%
OCF growth 3YN/A
OCF growth 5YN/A